A cólera é uma infeção diarreica aguda causada pela ingestão de água ou alimentos contaminados. Este curso providencia uma introdução geral à cólera e é dirigido aos profissionais que responde a surtos em emergências complexas ou em contextos onde as infraestruturas básicas ambientais f...oram danificadas ou destruídas.
more
全球COVID-19临床平台:与COVID-19暂时相关的儿童和青少年多系统炎症综合征疑似病例的病例报告表
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection.... Preliminary
evidence suggests that HIV infection may increase the risk of BU disease (1–3). In the Médecins Sans Frontières project in Akonolinga, Cameroon, HIV prevalence was approximately 3–6 times higher among BU patients than the regional estimated HIV prevalence (2). Similarly in Benin and Ghana, BU
patients were 8 times and 3 times respectively more likely to have HIV infection than those without BU (1, 3). Further study is needed to clarify this association and enhance knowledge about the prevalence ofBU–HIV coinfection in endemic areas.
more
En mayo de 2015, la 68.a Asamblea Mundial de la Salud reconoció la importancia del problema de salud pública que supone la resistencia a los antimicrobianos (RAM) y adoptó un Plan de acción mundial sobre la resistencia a los antimicrobianos (en adelante, el ‘Plan de ...acción mundial’) que propone intervenciones para controlar dicha resistencia, y en particular para reducir el uso innecesario de antimicrobianos en el ser humano y los animales
more
Временное руководство2 ноября 2020 г.
Это временное руководство представляет собой обновление более ранней версии, опубликованной 31 мая 2020 г. в качестве «Согласован...ных модулей оценки медицинских учреждений в условиях пандемии COVID-19». В этом обновленном руководстве содержание модулей было уточнено и доработано.
more
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.